Founder Details Launching Biotech Without a Degree
Armaan Dhanda, founder of Anomaly Bio, shared his story of dropping out of college twice to launch his startup. After internships at MIT and IIT, he raised $2.6 million to build the company in Singapore without completing a full degree.
- Anomaly Bio's core business involves engineering microbes to function as "micro-factories" for producing bio-based ingredients, aiming to create more resilient supply chains for industries like nutrition, personal care, and crop protection. - The company was co-founded by Armaan Dhanda and Samyak Baid, who met during their freshman week at the National University of Singapore in 2022 and had previously launched a venture creating vegan pet supplements. - The startup's pre-seed funding was led by US-based Pebblebed Ventures, with participation from notable tech executives from companies like Notion, Solugen, and Ecovative. - Anomaly Bio is leveraging Singapore's extensive biotech infrastructure by partnering with government-supported platforms like ScaleUp Bio for pilot-scale fermentation, rather than building its own costly facilities from scratch. - Singapore has actively cultivated a biotech hub through initiatives like the Biopolis research park and the Research, Innovation and Enterprise (RIE) 2025 plan, a S$25 billion government investment to support deep tech and science. - While a traditional patient-facing medical career requires an M.D., tech-focused biotech roles often have different educational paths; for example, a computational biologist typically needs a strong foundation in computer science and data analysis, often with a master's degree, while lab roles can be entered with a bachelor's degree. - A technical path in biotechnology without an advanced degree can lead to roles like lab assistant or manufacturing technologist, whereas careers in clinical research or genetic counseling require specific certifications and often a master's degree to be patient-facing. - Prior to its $2.6 million seed round, Anomaly Bio had already secured over $120,000 in non-dilutive funding through awards from MIT and the WTFund Fellowship, as well as support from Mars Petcare.
